PRN: Global Biosimilars Market Size and Forecast 2014-2017 & 2025 - Focus on Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, and Recombinant Peptides

21/ago/2017 19:45:10 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Biosimilars Market Size and Forecast 2014-2017 & 2025 - Focus on Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, and Recombinant Peptides

 
[21-August-2017]
 

DUBLIN, August 21, 2017 /PRNewswire/ --

The "Global Biosimilars Market Size and Forecast (2014-2025)" report has been added to Research and Markets' offering.

Research and Markets Logo

The main objective of the study is to estimate the global market size of the Biosimilars in terms of the value (US$ Million), and forecast of the same till 2025. The report also aims at deriving a comprehensive data showing the growth in consumption of Biosimilars in the recent years. The study also aim at highlighting potential growth opportunities in the coming years, while reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to the global Biosimilars market. In addition, the study focuses on a wealth of information on Biosimilars producers and suppliers.

Key Topics:

- Identify Biosimilars market size for the year 2013-2015 and forecast the same till 2025
- Deriving data for Biosimilars, By Region, By Type and By Application
- Identify major driving factors, restraints, challenges for the Biosimilars
- and highlight the potential growth o! pportunities in the coming years
- Competitive analysis of Biosimilars Producers

Key Topics Covered:

1. Introduction
1.1 Objective of the Study
1.2 Scope of the Study
1.2.1 Market Definition
1.2.2 Market Scope
1.2.3 Market Segmentation
1.2.4 Assumptions & Limitations
1.3 Stake Holders of the Report

2. Research Methodology
2.1 Objective of the Study
2.2 Market Size Estimation
2.3 Market Share Estimation

3. Executive Summary
2.3.1 Key Points from Primary Research
2.3.2 Key Points from Secondary Research
3.1 Executive Summary

4. Market Overview
4.1 Market Drivers
4.2 Market Restraints
4.3 Regulatory Analysis:  EMA, US FDA, Latin America and Rest of the World
4.4 Market Opportunity
4.5 Market Entry Analysis
4.4 Average Price Analysis
4.5 Stake Holder Analysis

5. Biosimilar! s Market, By Product Type
5.1 Introduction
5.2 Globa! l Biosim ilars Market, By Types: Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, and Recombinant Peptides

6. Biosimilars Market, By Application
6.1 Introduction
6.2. Global Biosimilars Market, By Application: Oncology, Blood Disorder, Infection, Autoimmune and Others
6.3 North America Biosimilars Market, By Country: U.S. and Canada
6.4 Europe Biosimilars Market, By Country: UK, Germany and France
6.5 Asia-Pacific Biosimilars Market, By Country: India and China
6.6 Latin America Biosimilars Market, By Country: Brazil, Mexico
6.6 GCC countries Biosimilars Market, By Country: UAE, Soudi Arabia
6.6 Africa Biosimilars Market, By Country: South Africa, North Africa

7. Biosimilars Market, Regional Analysis
7.1 Global Biosimilars Market, By Region
7.2 Global Biosimilars Market, By Region
7.2.1 Biosimilars Market Regional Outlook, by Major Countries

8. Company Profiles

- AstraZeneca
- Biocon Ltd.
- Novartis
- Pfizer Inc.

For more information about this report visit https://www.researchandmarkets.com/research/mlf2z9/global

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl